PharmaShots | Incisive News in 3 Shots

Subscribe Now

Newly Diagnosed Light-chain (AL) Amyloidosis

Genmab's Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA's Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Genmab's Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA's Approval for Patients with Newly Diagnosed Lig...

January 18, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us